Articles

Results 1 to 5 of 22
Most popular |Most recent


SEC Amends Exempt Offering Framework

USA - November 20 2020 On November 2, 2020, the Securities and Exchange Commission (SEC) voted to amend the framework for exempt offerings under the Securities Act of 1933…

Mark J. Mihanovic, Robert H. Cohen, Thomas P. Conaghan, Ze’-ev D. Eiger.

SEC Modernizes “Accredited Investor” Definition

USA - August 27 2020 On August 26, 2020, the US Securities and Exchange Commission (the SEC or “Commission”) adopted amendments to the definition of “accredited investor”…

Diana Douglas, Eric Orsic, Heidi Steele, Mark J. Mihanovic, Mark S. Selinger, Robert H. Cohen, Thomas P. Conaghan, Ze’-ev D. Eiger.

SEC Provides Further Guidance on COVID-19 Disclosure

USA - July 1 2020 On June 23, 2020, the Division of Corporation Finance (CF) and the Office of the Chief Accountant of the US Securities and Exchange Commission (SEC)…

Eric Orsic, Heidi Steele, Mark J. Mihanovic, Patrick F. Healy, Richard Bass, Robert H. Cohen, Thomas P. Conaghan, Ze’-ev D. Eiger.

Capital Markets & Public Companies Quarterly

USA - October 17 2019 On September 6, 2019, the Staff of the Division of Corporation Finance of the US Securities and Exchange Commission (SEC) announced two major changes…

Daniel L. Woodard, Eric Orsic, Heidi Steele, Mark J. Mihanovic, Robert H. Cohen, Thomas J. Murphy, Thomas P. Conaghan, William Hadler.

Life Sciences Company Settles Regulation FD Charges with SEC

USA - September 4 2019 On August 20, 2019, the US Securities and Exchange Commission (SEC) charged TherapeuticsMD Inc., a Boca Raton, Florida, headquartered life sciences…

Eric Orsic, Mark S. Selinger, Thomas P. Conaghan.